By late 2025, the global nasal spray market has consolidated significantly, with the top two manufacturers alone controlling approximately 27% of the total market share. GlaxoSmithKline (GSK) remains the global leader with a 15% share, driven by its robust portfolio of 12 branded products, including Avamys and Veramyst. GSK's focus in 2025 has shifted toward "circular economy" initiatives,...

By late 2025, the global nasal spray market has consolidated significantly, with the top two manufacturers alone controlling approximately 27% of the total market share. GlaxoSmithKline (GSK) remains the global leader with a 15% share, driven by its robust portfolio of 12 branded products, including Avamys and Veramyst. GSK's focus in 2025 has shifted toward "circular economy" initiatives,...